We have demonstrated that down-regulation of Gal-3 by ShRNA in several pancreatic cancer cell lines with high constitutive Gal-3 expression decreases cell proliferation and invasion in vitro and tumor volume and size in vivo in an orthotopic pancreatic cancer mouse model. This evidence concerns the gene LGALS3 and familial pancreatic carcinoma.